Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/IMP321> ?p ?o }
- IMP321 abstract "IMP321 is a large molecule cancer drug being developed by the clinical stage biotechnology company Prima BioMed (Nasdaq: PBMD). The drug is Prima's lead compound.IMP321 is soluble version of the immune checkpoint molecule LAG3, used to increase an immune response to tumours. The drug is administered by subcutaneous injection. IMP321 has two intended clinical settings, 'low dose' (for example 250 µg) as adjuvant to cancer vaccines and 'high dose' (such as 12 injections of 6 mg each) as first-line 'chemo-immunotherapy', that is, combined with standard chemotherapy. IMP321 has been in Phase II clinical testing. The product has been shown to be non-immunogenic, that is, no anti-IMP321 antibodies have been detected in clinical trials. Currently the main indication for the drug is metastatic breast cancer.".
- IMP321 wikiPageID "46557481".
- IMP321 wikiPageLength "34821".
- IMP321 wikiPageOutDegree "122".
- IMP321 wikiPageRevisionID "706551825".
- IMP321 wikiPageWikiLink 15th_arrondissement_of_Paris.
- IMP321 wikiPageWikiLink 20th_arrondissement_of_Paris.
- IMP321 wikiPageWikiLink Adjuvant.
- IMP321 wikiPageWikiLink Adoptive_cell_transfer.
- IMP321 wikiPageWikiLink American_Society_of_Clinical_Oncology.
- IMP321 wikiPageWikiLink Antibody.
- IMP321 wikiPageWikiLink Antigen-presenting_cell.
- IMP321 wikiPageWikiLink Atomic_mass_unit.
- IMP321 wikiPageWikiLink B_cell.
- IMP321 wikiPageWikiLink Breast_cancer.
- IMP321 wikiPageWikiLink Brussels.
- IMP321 wikiPageWikiLink C-C_chemokine_receptor_type_7.
- IMP321 wikiPageWikiLink CD27.
- IMP321 wikiPageWikiLink CD28.
- IMP321 wikiPageWikiLink CD38.
- IMP321 wikiPageWikiLink CD40_(protein).
- IMP321 wikiPageWikiLink CD69.
- IMP321 wikiPageWikiLink CD8.
- IMP321 wikiPageWikiLink Cancer.
- IMP321 wikiPageWikiLink Cancer_Letters.
- IMP321 wikiPageWikiLink Cancer_Research_(journal).
- IMP321 wikiPageWikiLink Cancer_vaccine.
- IMP321 wikiPageWikiLink Category:Experimental_cancer_drugs.
- IMP321 wikiPageWikiLink Central_memory_T_cell.
- IMP321 wikiPageWikiLink Chemoimmunotherapy.
- IMP321 wikiPageWikiLink China.
- IMP321 wikiPageWikiLink Chinese_hamster_ovary_cell.
- IMP321 wikiPageWikiLink ClinicalTrials.gov.
- IMP321 wikiPageWikiLink Clinical_Cancer_Research.
- IMP321 wikiPageWikiLink Cliniques_Universitaires_Saint-Luc.
- IMP321 wikiPageWikiLink Cytotoxic_T_cell.
- IMP321 wikiPageWikiLink DNA_vaccination.
- IMP321 wikiPageWikiLink Dendritic_cell.
- IMP321 wikiPageWikiLink Eddingpharm.
- IMP321 wikiPageWikiLink EudraCT.
- IMP321 wikiPageWikiLink European_Union.
- IMP321 wikiPageWikiLink French_Institute_of_Health_and_Medical_Research.
- IMP321 wikiPageWikiLink Freunds_adjuvant.
- IMP321 wikiPageWikiLink Frédéric_Triebel.
- IMP321 wikiPageWikiLink Fusion_protein.
- IMP321 wikiPageWikiLink GVAX.
- IMP321 wikiPageWikiLink Gemcitabine.
- IMP321 wikiPageWikiLink GlaxoSmithKline.
- IMP321 wikiPageWikiLink Granulocyte_macrophage_colony-stimulating_factor.
- IMP321 wikiPageWikiLink HBsAg.
- IMP321 wikiPageWikiLink neu.
- IMP321 wikiPageWikiLink HLA-DR.
- IMP321 wikiPageWikiLink Hepatocellular_carcinoma.
- IMP321 wikiPageWikiLink Hong_Kong.
- IMP321 wikiPageWikiLink Hôpital_Européen_Georges-Pompidou.
- IMP321 wikiPageWikiLink Immune_checkpoint.
- IMP321 wikiPageWikiLink Immunodeficiency.
- IMP321 wikiPageWikiLink Immunoglobulin_G.
- IMP321 wikiPageWikiLink Institut_Gustave_Roussy.
- IMP321 wikiPageWikiLink Interleukin_10.
- IMP321 wikiPageWikiLink Interleukin_12.
- IMP321 wikiPageWikiLink Journal_of_Immunology.
- IMP321 wikiPageWikiLink Journal_of_Translational_Medicine.
- IMP321 wikiPageWikiLink L-selectin.
- IMP321 wikiPageWikiLink LAG3.
- IMP321 wikiPageWikiLink Lausanne_University_Hospital.
- IMP321 wikiPageWikiLink Lead_compound.
- IMP321 wikiPageWikiLink Ligand.
- IMP321 wikiPageWikiLink Lonza_Group.
- IMP321 wikiPageWikiLink MAGE-3.A2.
- IMP321 wikiPageWikiLink MAGE-A3-DP4.
- IMP321 wikiPageWikiLink MHC_class_II.
- IMP321 wikiPageWikiLink MLANA.
- IMP321 wikiPageWikiLink Macau.
- IMP321 wikiPageWikiLink Macromolecule.
- IMP321 wikiPageWikiLink Memory_T_cell.
- IMP321 wikiPageWikiLink Merck_Serono.
- IMP321 wikiPageWikiLink Metastasis.
- IMP321 wikiPageWikiLink Milan.
- IMP321 wikiPageWikiLink NA-17.
- IMP321 wikiPageWikiLink NASDAQ.
- IMP321 wikiPageWikiLink NEC.
- IMP321 wikiPageWikiLink NY-ESO-1.
- IMP321 wikiPageWikiLink Natural_killer_cell.
- IMP321 wikiPageWikiLink Ovalbumin.
- IMP321 wikiPageWikiLink P-value.
- IMP321 wikiPageWikiLink PTPRC.
- IMP321 wikiPageWikiLink Paclitaxel.
- IMP321 wikiPageWikiLink Paris.
- IMP321 wikiPageWikiLink Peptide_vaccine.
- IMP321 wikiPageWikiLink Peripheral_blood_mononuclear_cell.
- IMP321 wikiPageWikiLink Prima_BioMed.
- IMP321 wikiPageWikiLink Protein_dimer.
- IMP321 wikiPageWikiLink Recombinant_DNA.
- IMP321 wikiPageWikiLink Response_Evaluation_Criteria_in_Solid_Tumors.
- IMP321 wikiPageWikiLink Saint-Cloud.
- IMP321 wikiPageWikiLink South_San_Francisco,_California.
- IMP321 wikiPageWikiLink St._Louis.
- IMP321 wikiPageWikiLink Statistical_significance.
- IMP321 wikiPageWikiLink Subcutaneous_injection.